Changes in gene expression contribute to cancer prevention by COX inhibitors

Progress in Lipid Research

Volumn 45, Issue 1, 2006, Pages 1-16

  Baek, Seung Joon ^a   Eling, Thomas E ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

AA; COX; GDF 15; LOX; MIC 1; NAG 1; NSAIDs

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; ACETYLSALICYLIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CAPSAICIN; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; GENE PRODUCT; GENISTEIN; IBUPROFEN; INDOMETACIN; LINOLEIC ACID; LYCOPENE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROSTAGLANDIN SYNTHASE; PROTEIN NSAID ACTIVATED GENE 1; PROTEIN P53; RESVERATROL; ROFECOXIB; SALICYLATE SODIUM; SULINDAC; SULINDAC SULFIDE; SULINDAC SULFONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DRUG ACTIVITY; DRUG EFFECT; ENVIRONMENTAL FACTOR; GASTROINTESTINAL SYMPTOM; GENE CONTROL; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE INHIBITORS; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASMS; PROSTAGLANDINS;

EID: 31644433902     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2005.10.001     Document Type: Review

References (72)

1. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, and E. Ward Cancer statistics 2004 CA Cancer J Clin 54 2004 8 29
2. J.C. Johnson, J.A. DiSario, and W.M. Grady Surveillance and treatment of periampullary and duodenal adenomas in familial adenomatous polyposis Curr Treat Options Gastroenterol 7 2004 79 89
3. M.J. Thun, S.J. Henley, and C. Patrono Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J Natl Cancer Inst 94 2002 252 266
4. Y. Beazer-Barclay, D.B. Levy, A.R. Moser, W.F. Dove, S.R. Hamilton, and B. Vogelstein Sulindac suppresses tumorigenesis in the Min mouse Carcinogenesis 17 1996 1757 1760
5. C.H. Chiu, M.F. McEntee, and J. Whelan Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis Cancer Res 57 1997 4267 4273
6. H.R. Herschman Prostaglandin synthase 2 Biochim Biophys Acta 1299 1996 125 140
7. L.J. Marnett, and R.N. DuBois COX-2: a target for colon cancer prevention Annu Rev Pharmacol Toxicol 42 2002 55 80
8. H.F. Tiano, C.D. Loftin, J. Akunda, C.A. Lee, J. Spalding, and A. Sessoms Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis Cancer Res 62 2002 3395 3401
9. P.C. Chulada, M.B. Thompson, J.F. Mahler, C.M. Doyle, B.W. Gaul, and C. Lee Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice Cancer Res 60 2000 4705 4708
10. M. Oshima, J.E. Dinchuk, S.L. Kargman, H. Oshima, B. Hancock, and E. Kwong Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
11. T. Daikoku, D. Wang, S. Tranguch, J.D. Morrow, S. Orsulic, and R.N. DuBois Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer Cancer Res 65 2005 3735 3744
12. A.N. Hata, and R.M. Breyer Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacol Ther 103 2004 147 166
13. M. Sonoshita, K. Takaku, N. Sasaki, Y. Sugimoto, F. Ushikubi, and S. Narumiya Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice Nat Med 7 2001 1048 1051
14. S.-H. Chang, Y. Ai, R.M. Breyer, T.F. Lane, and T. Hla The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia Cancer Res 65 2005 4496 4499
15. J. Regan EP2 and EP4 prostanoid receptor signaling Life Sci 74 2003 143 153
16. M. Yan, R.M. Rerko, P. Platzer, D. Dawson, J. Willis, and M. Tong From the cover: 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-{beta}-induced suppressor of human gastrointestinal cancers PNAS 101 2004 17468 17473
17. H. Ikawa, H. Kamitani, B.F. Calvo, J.F. Foley, and T.E. Eling Expression of 15-lipoxygenase-1 in human colorectal cancer Cancer Res 59 1999 360 366
18. J.B. Nixon, K.S. Kim, P.W. Lamb, F.G. Bottone, and T.E. Eling 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer Prostaglandins Leukot Essent Fatty Acids 70 2004 7 15
19. S.B. Shappell, R.A. Gupta, S. Manning, R. Whitehead, W.E. Boeglin, and C. Schneider 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells Cancer Res 61 2001 497 503
20. S. Tang, B. Bhatia, C.J. Maldonado, P. Yang, R.A. Newman, and J. Liu Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells J Biol Chem 277 2002 16189 16201
21. L.C. Hsi, L.C. Wilson, and T.E. Eling Opposing effects of 15-Lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in Peroxisome Proliferator-Activated Receptor gamma J Biol Chem 277 2002 40549 40556
22. J.S. Kim, S.J. Baek, F.G. Bottone Jr, T. Sali, and T.E. Eling Overexpression of 15-Lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells Mol Cancer Res 3 2005 511 517
23. M. Yokoyama-Kobayashi, M. Saeki, S. Sekine, and S. Kato Human cDNA encoding a novel TGF-b superfamily protein highly expressed in placenta J Biochem 122 1997 622 626
24. M.R. Bootcov, A.R. Bauskin, S.M. Valenzuela, A.G. Moore, M. Bansal, and X.Y. He MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc Natl Acad Sci USA 94 1997 11514 11519
25. P.X. Li, J. Wong, A. Ayed, D. Ngo, A.M. Brade, and C. Arrowsmith Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression J Biol Chem 275 2000 20127 20135
26. V.M. Paralkar, A.L. Vail, W.A. Grasser, T.A. Brown, H. Xu, and S. Vukicevic Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family J Biol Chem 273 1998 13760 13767
27. M. Bottner, M. Laaff, B. Schechinger, G. Rappold, K. Unsicker, and C. Suter-Crazzolara Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1) Gene 237 1999 105 111
28. R. Hromas, M. Hufford, J. Sutton, D. Xu, Y. Li, and L. Lu PLAB, a novel placental bone morphogenetic protein Biochim Biophys Acta 1354 1997 40 44
29. L.N. Lawton, M.F. Bonaldo, P.C. Jelenc, L. Qiu, S.A. Baumes, and R.A. Marcelino Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta Gene 203 1997 17 26
30. M. Bottner, C. Suter-Crazzolara, A. Schober, and K. Unsicker Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues Cell Tissue Res 297 1999 103 110
31. E.C. Hsiao, L.G. Koniaris, T. Zimmers-Koniaris, S.M. Sebald, T.V. Huynh, and S.J. Lee Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury Mol Cell Biol 20 2000 3742 3751
32. S.J. Baek, J.M. Horowitz, and T.E. Eling Molecular cloning and characterization of human nonsteroidal anti- inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3 J Biol Chem 276 2001 33384 33392
33. A.R. Bauskin, H.P. Zhang, W.D. Fairlie, X.Y. He, P.K. Russell, and A.G. Moore The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1 EMBO J 19 2000 2212 2220
34. A.R. Bauskin, D.A. Brown, S. Junankar, K.K. Rasiah, S. Eggleton, and M. Hunter The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome Cancer Res 65 2005 2330 2336
35. S.J. Baek, L.C. Wilson, C.H. Lee, and T.E. Eling Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene J Pharmacol Exp Ther 301 2002 1126 1131
36. S.J. Baek, L.C. Wilson, and T.E. Eling Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 Carcinogenesis 23 2002 425 432
37. L.C. Wilson, S.J. Baek, A. Call, and T.E. Eling Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells Int J Cancer 105 2003 747 753
38. F.G. Bottone Jr, S.J. Baek, J.B. Nixon, and T.E. Eling Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells J Nutr 132 2002 773 778
39. S.H. Lee, J.S. Kim, K. Yamaguchi, T.E. Eling, and S.J. Baek Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner Biochem Biophys Res Commun 328 2005 63 69
40. S.J. Baek, J.S. Kim, J.B. Nixon, R.P. DiAugustine, and T.E. Eling Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1 J Biol Chem 279 2004 6883 6892
41. A. Monks, E. Harris, C. Hose, J. Connelly, and E.A. Sausville Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3- methylphenyl)-5-fluorobenzothiazole Mol Pharmacol 63 2003 766 772
42. D. Newman, M. Sakaue, J.S. Koo, K.S. Kim, S.J. Baek, and T. Eling Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids Mol Pharmacol 63 2003 557 564
43. K.S. Kim, J.H. Shin, S.J. Baek, and J.H. Yoon Expression of non-steroidal anti-inflammatory drug-activated gene-1 in human nasal mucosa and cultured nasal epithelial cells: a preliminary investigation Acta Otolaryngol 123 2003 857 861
44. K.S. Kim, J.H. Yoon, J.K. Kim, S.J. Baek, T.E. Eling, and W.J. Lee Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene Biochem Biophys Res Commun 325 2004 1298 1303
45. M. Shim, and T.E. Eling Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells J Biol Chem 280 2005 18636 18642
46. S.J. Baek, J.S. Kim, S.M. Moore, S.H. Lee, J. Martinez, and T.E. Eling Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein Mol Pharmacol 67 2005 356 364
47. P. Srivastava, J. Russo, O.P. Mgbonyebi, and I.H. Russo Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells Anticancer Res 18 1998 4003 4010
48. E.L. Decker, C. Skerka, and P.F. Zipfel The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells J Biol Chem 273 1998 26923 26930
49. K. Detmer, T.A. Steele, M.A. Shoop, and H. Dannawi Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines Blood Cells Mol Dis 25 1999 310 323
50. S.J. Baek, K.S. Kim, J.B. Nixon, L.C. Wilson, and T.E. Eling Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities Mol Pharmacol 59 2001 901 908
51. M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway Proc Natl Acad Sci USA 97 2000 109 114
52. M. Albertoni, P.H. Shaw, M. Nozaki, S. Godard, M. Tenan, and M.F. Hamou Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 Oncogene 21 2002 4212 4219
53. K.S. Kim, S.J. Baek, G.P. Flake, C.D. Loftin, B.F. Calvo, and T.E. Eling Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue Gastroenterology 122 2002 1388 1398
54. D.A. Brown, R.L. Ward, P. Buckhaults, T. Liu, K.E. Romans, and N.J. Hawkins MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma Clin Cancer Res 9 2003 2642 2650
55. D.H. Lee, Y. Yang, S.J. Lee, K.Y. Kim, T.H. Koo, and S.M. Shin Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system Cancer Res 63 2003 4648 4655
56. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, J. Wang-Rodriguez, and C.A. Moskaluk Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer Cancer Res 61 2001 5974 5978
57. D. Karan, S.J. Chen, S.L. Johansson, A.P. Singh, V.M. Paralkar, and M.F. Lin Dysregulated expression of MIC-1/PDF in human prostate tumor cells Biochem Biophys Res Commun 305 2003 598 604
58. R. Thomas, L.D. True, P.H. Lange, and R.L. Vessella Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: relation to tumor development and progression Int J Cancer 93 2001 47 52
59. D.A. Brown, A.R. Bauskin, W.D. Fairlie, M.D. Smith, T. Liu, and N. Xu Antibody-based approach to high-volume genotyping for MIC-1 polymorphism Biotechniques 33 2002 118 120 122, 124 passim
60. F. Lindmark, S.L. Zheng, F. Wiklund, J. Bensen, K.A. Balter, and B. Chang H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer J Natl Cancer Inst 96 2004 1248 1254
61. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
62. B. Vogelstein, E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, and M. Leppert Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
63. K.W. Kinzler, M.C. Nilbert, B. Vogelstein, T.M. Bryan, D.B. Levy, and K.J. Smith Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers Science 251 1991 1366 1370
64. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
65. Y. Kishimoto, T. Morisawa, A. Hosoda, G. Shiota, H. Kawasaki, and J. Hasegawa Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane J Exp Clin Cancer Res 21 2002 203 211
66. A. Papanikolaou, Q.S. Wang, D. Papanikolaou, H.E. Whiteley, and D.W. Rosenberg Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis Carcinogenesis 21 2000 1567 1572
67. M. Takahashi, M. Mutoh, T. Kawamori, T. Sugimura, and K. Wakabayashi Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis Carcinogenesis 21 2000 1319 1327
68. J.M. Ward, R.S. Yamamoto, and C.A. Brown Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane J Natl Cancer Inst 51 1973 1029 1039
69. A.C. Povey, A.F. Badawi, D.P. Cooper, C.N. Hall, K.L. Harrison, and P.E. Jackson DNA alkylation and repair in the large bowel: animal and human studies J Nutr 132 2002 3518S 3521S
70. F.G. Bottone Jr, Y. Moon, J.S. Kim, B. Alston-Mills, M. Ishibashi, and T.E. Eling The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3) Mol Cancer Ther 4 2005 693 703
71. C. Liu, V.M. Rangnekar, E. Adamson, and D. Mercola Suppression of growth and transformation and induction of apoptosis by EGR-1 Cancer Gene Ther 5 1998 3 28
72. R.P. Huang, Y. Fan, I. de Belle, C. Niemeyer, M.M. Gottardis, and D. Mercola Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation Int J Cancer 72 1997 102 109